Costimulatory molecule OX40L is critical for both Th1 and Th2 responses in allergic inflammation
about
Airway wall expression of OX40/OX40L and interleukin-4 in asthmaCD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction.OX40L blockade and allergen-induced airway responses in subjects with mild asthmaOX40-OX40L interaction promotes proliferation and activation of lymphocytes via NFATc1 in ApoE-deficient mice.The significance of OX40 and OX40L to T-cell biology and immune disease.Activation of OX40 prolongs and exacerbates autoimmune experimental uveitisRole of T cell co-stimulation in murine models of allergic asthma.OX40/OX40 ligand interactions in T-cell regulation and asthmaTherapeutic targeting of the effector T-cell co-stimulatory molecule OX40.TLR2 and TLR4 stimulation differentially induce cytokine secretion in human neonatal, adult, and murine mononuclear cells.Co-stimulatory molecules as potential targets for therapeutic intervention in allergic airway disease.(R)-albuterol decreases immune responses: role of activated T cellsResponsiveness to respiratory syncytial virus in neonates is mediated through thymic stromal lymphopoietin and OX40 ligand.Cellular and molecular mechanisms of TSLP function in human allergic disorders--TSLP programs the "Th2 code" in dendritic cells.The costimulatory molecule SLAM is critical for pulmonary allergic responses.TNF superfamily: costimulation and clinical applicationsCritical Role of Transcription Factor PU.1 in the Function of the OX40L/TNFSF4 Promoter in Dendritic Cells.The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseasesDiesel exhaust particle-treated human bronchial epithelial cells upregulate Jagged-1 and OX40 ligand in myeloid dendritic cells via thymic stromal lymphopoietin.4-1 BB stimulation inhibits allergen-specific immunoglobulin E production and airway hyper-reactivity but partially suppresses bronchial eosinophilic inflammation in a mouse asthma model.The future of cancer treatment: immunomodulation, CARs and combination immunotherapy.Human metapneumovirus infection activates the TSLP pathway that drives excessive pulmonary inflammation and viral replication in mice.Serum biomarkers for allergy in children.Anti-OX40L alone or in combination with anti-CD40L and CTLA4Ig does not inhibit the humoral and cellular response to a major grass pollen allergen.OX40 blockade inhibits house dust mite driven allergic lung inflammation in mice and in vitro allergic responses in humans.OX40-OX40L interactions: a promising therapeutic target for allergic diseases?Developments in the field of allergy in 2016 through the eyes of Clinical and Experimental Allergy.Effect of anti-CD134L mAb and CTLA4Ig on ConA-induced proliferation, Th cytokine secretion, and anti-dsDNA antibody production in spleen cells from lupus-prone BXSB mice.Crucial role of OX40/OX40L signaling in a murine model of asthma.Toll-like receptor 4 or 2 agonists decrease allergic inflammation.The costimulatory molecules CD80, CD86 and OX40L are up-regulated in Aspergillus fumigatus sensitized mice.
P2860
Q33776845-8250CD85-6719-4077-BFED-D4BD0A221CA6Q34599954-E3EA4B9D-A33B-4E7B-8A16-D49C113CCB99Q34620982-3D5EBD77-E112-4E8C-BC24-91E9159C6885Q34674266-DCC3A0D6-1846-4CCA-8BAB-F88073FBFB4AQ34979946-D15DD21D-3943-4170-AF9B-DE6D55DFEC99Q35524673-FE1006A5-5153-4DE2-8A37-456F32C08994Q35628016-73E2528C-CBA2-44F6-AE5A-CEC8F2376AD1Q35750177-A1F52668-98B6-4823-BE03-9B39EC9F38C9Q35790354-3DB57D0B-CE55-471A-B66E-CF6D45EBE7DDQ36106287-3BBFC29F-48FC-46D4-BAE5-3AD3F9EE22E4Q36360561-C6B30BDD-BCB1-4BA4-BD47-6D8FC0D25DBDQ36477130-1E9A2414-4350-4F35-B4DB-81D38E82DF1BQ36672339-DE3DA9B3-FE9F-46E7-BE89-DE2AE8F7AD8FQ36865256-84E49D3D-2A25-4207-BB06-424AAABF47A5Q37098572-049F72F9-C576-4044-87CF-108CEF531925Q37266849-EF22DD09-AB9E-4499-BA37-C68EC15AB512Q37314799-E23FA0FD-D932-4A7D-9F3A-168A4F71A408Q37382950-4DA81AF2-0CA8-459A-BF62-25DB13B6F983Q37590222-6244465D-3A34-417B-865F-978FAF4D30ADQ38511041-8E95722B-732B-4AC2-ADFD-147BE8FA6FD2Q38775177-02678061-AA64-452F-8448-F28AEA170711Q38900807-12A45037-FAFD-4ED2-B2E1-A90A8B741D95Q38945312-ED1DB6A4-442D-4C75-80F0-285AD1D14433Q40435122-FEA07B29-2F25-42A1-ABE8-C715848938F6Q41643876-1A883E13-EF7C-450D-AA10-4701E9ADEFA7Q41849418-82A22C20-7374-45B9-B1B0-8414D9AB67DCQ45070970-0C74EE82-4179-4150-B375-9415717D9F64Q46528185-AEBC2305-4918-43C4-9C7E-E5F3939AF720Q47654169-EF1F80FD-55AD-4ADB-A36F-DC6F1541A301Q47886019-F97C2A5B-BD0E-4C1B-8D4D-CA95654CE679Q53653073-EEC4A661-15FE-4932-9404-E14537243134
P2860
Costimulatory molecule OX40L is critical for both Th1 and Th2 responses in allergic inflammation
description
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2002
@ast
im Oktober 2002 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2002/10/01)
@sk
vědecký článek publikovaný v roce 2002
@cs
wetenschappelijk artikel (gepubliceerd op 2002/10/01)
@nl
наукова стаття, опублікована в жовтні 2002
@uk
مقالة علمية (نشرت في أكتوبر 2002)
@ar
name
Costimulatory molecule OX40L i ...... onses in allergic inflammation
@ast
Costimulatory molecule OX40L i ...... onses in allergic inflammation
@en
Costimulatory molecule OX40L i ...... onses in allergic inflammation
@nl
type
label
Costimulatory molecule OX40L i ...... onses in allergic inflammation
@ast
Costimulatory molecule OX40L i ...... onses in allergic inflammation
@en
Costimulatory molecule OX40L i ...... onses in allergic inflammation
@nl
prefLabel
Costimulatory molecule OX40L i ...... onses in allergic inflammation
@ast
Costimulatory molecule OX40L i ...... onses in allergic inflammation
@en
Costimulatory molecule OX40L i ...... onses in allergic inflammation
@nl
P2093
P3181
P1476
Costimulatory molecule OX40L i ...... onses in allergic inflammation
@en
P2093
Andy I. Chen
Arlene H. Sharpe
David L. Perkins
Hongzhen He
Patricia W. Finn
Robert M. Westlake
Ruth S. S. Arestides
P304
P3181
P356
10.1002/1521-4141(2002010)32:10<2874::AID-IMMU2874>3.0.CO;2-4
P407
P577
2002-10-01T00:00:00Z